BrainCarta

Functional MRI is increasingly included in planning for neurosurgical operations, mostly for removal of a tumor, or of the source of seizures in epilepsy. fMRI can provide locations of important brain areas that need to be spared. Due to complexity in acquiring and evaluating fMRI data, very few hospitals have the capability to perform clinical fMRI. BrainCarta is a spin-off company from the UMC that will enable radiology departments to provide functional MRI scans to neurologists and neurosurgeons even without specialists on site. Goal is to improve chances of tumor patients to early surgical removal, by increasing availability of fMRI in surgical decision making. The start up is funded in part with a Valorisation Phase 2 grant (equal to an SBIR grant) from STW.

 

June 2015: Braincarta is moving closer to becoming a company. Critical funding from investors is likely to be realized in the summer of 2015, negotiations are ongoing. With the news funds the software can be completed and beta testing can start. We expect to be able to deliver our commercial service by early 2016.